2015 icrc logo
5th Int. CeBiTec Research Conference

Drug Conjugates for Directed Therapy

Center for Interdisciplinary Research (ZiF), Bielefeld University, Germany
September 20 – 23, 2015


The Center for Biotechnology (CeBiTec) of Bielefeld University cordially invites you to attend the 5th International CeBiTec Research Conference on "Drug Conjugates in Directed Therapy”.

CeBiTec Research Conferences are annual events with thematic focus on a challenging topic in the life sciences. The 2015 conference "Drug Conjugates for Directed Therapy" is being organized by the Marie Skłodowska-Curie European Training Network (ETN) MAGICBULLET, which is currently being funded by the EU in the Horizon 2020 Framework Programme for Research and Innovation.

The scope of the CeBiTec Research Conference will include:

• Antibody-Drug Conjugates
• Peptide-Drug Conjugates
• Targets and Specificity
• New Drugs
• Linker Technologies
• Applications
• Process Development

The conference will be held at the Center for Interdisciplinary Research (ZiF) of Bielefeld University from September 20th to 23rd, 2015.

Conference Schedule

Conference Flyer


 Confirmed speakers

Jan Anderl Heidelberg Pharma, DE

Antibody-Drug Conjugates Based on RNA Polymerase II Inhibiting Payloads


James Baker University College London, UK

The Next Generation Maleimide platform for the construction of homogeneous protein conjugates


Annette Beck-Sickinger Leipzig University, DE

Targeted cancer diagnosis and therapy with peptide conjugates


Ravi J. Chari ImmunoGen, Waltham, US

Antibody-Drug Conjugates: Pathway from a concept to the clinic


Donald M. Engelman Yale University, US

pHLIP® targeting and delivery of PNA in vivo to silence microRNA in acidic tumor cells


Cesare Gennari Universitá degli Studi di Milano, IT

Tumor targeting via integrin ligands: Synthesis and biological evaluation of RGD peptidomimetic-Paclitaxel conjugates


Ulf Grawunder NBE Therapeutics, CH

SMAC-Technology – generation of site-specifically conjugated ADCs by highly efficient enzymatic conjugation


Nicolas Joubert Université de Tours, FR

A new chemical platform for the modular construction of homogeneous Antibody-Drug Conjugates


Horst Kessler TU München, DE

Selective addressing integrin subtypes for drug research, molecular imaging and biophysical studies


Felix Kratz CytRx Corporation, DE 

Albumin-based drug delivery systems in oncology: From bench to bedside


Pirjo Laakkonen Biomedicum Helsinki, FI

Peptide-based tumor targeting


Maxime Lampilas Sanofi, Vitry sur Seine, FR

Process development of SPDB/DM4 conjugates


Hans-Georg Lerchen Bayer, DE

Targeted drug conjugates: Challenges in the interface between small molecules and proteins


Marilena Manea University of Konstanz, DE

Drug delivery systems containing GnRH-III peptide as a targeting moiety


Gábor Mező MTA-ELTE, HU

Dual targeting with cyclic NGR peptides


Ines Neundorf University of Cologne, DE

Design and application of cell-penetrating peptides as drug delivery vehicles


Umberto Piarulli Università degli Studi dell'Insubria, IT

Synthesis and biological evaluation of integrin and dual integrin-VEGFR ligands for tumor targeting therapy


Doron Shabat Tel Aviv University, IL

Distinct Developments in Linker Technologies for Bioconjugation


Fred Valeriote Henry Ford Health System, Detroit, US

Discovery of anticancer leads as potential drug conjugates


You also may actively participate in the symposium by presenting your work in oral presentations (nearly ten time slots for 20 min oral communications are available) and poster presentations.

We look forward to your contribution!



Please register to the conference by using the ONLINE REGISTRATION.

Participation will be limited to 140 persons. The registration will be open till August 31st, 2015.


Submission of Abstracts

Please submit your poster or short oral presentation abstract by using the online registration above.

Please apply for

Oral presentation: abstract submission by June 1st, 2015

Poster presentation: abstract submission by August 24th, 2015

Only .doc/.docx or .rtf files can be submitted.

For abstracts, please use the template provided HERE


Registration fee

Attendee's affiliation/status:

Until August 21st, 2015

After August 21st, 2015

Junior Scientist

€ 150

Junior Scientist € 200

Senior Scientist

€ 300

Senior Scientist € 350

Industry Attendee

€ 500

Industry Attendee € 600

(Junior scientist applies to: Students, PhD students, Postdoctoral research fellows max. two years after PhD graduation).

The registration fee covers the conference materials including book of abstracts, snacks, coffee and lunch as well as the conference dinner.

Please follow the payment details provided by the ONLINE REGISTRATION process.



You are encouraged to book your accommodation in the Park Inn conference hotel, which provide special rates for conference participants (available until August 21st, 2015).

Single bedroom (including breakfast): Euro 79,-

Double bedroom upon request

Please make your reservations mentioning group reference 24421 at

Park Inn by Radisson Bielefeld
Telephone: +49 521 9238-0
Fax: +49 521 9238-250
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Conference venue

The conference will be held at the Center for Interdisciplinary Research (ZiF) of Bielefeld University, Methoden 1, 33615 Bielefeld.


Travel Information

Detailed information on how to travel to Bielefeld and the Center for Interdisciplinary Research of Bielefeld University can be found HERE.


Further Information

For further information please contact This email address is being protected from spambots. You need JavaScript enabled to view it.


MAGICBULLET consortium and scientific committee of the 5th International CeBiTec Research Conference:

Cesare Gennari Universitá degli Studi di Milano, IT
Pirjo Laakkonen University of Helsinki, FI
Gábor Mező Eőtvős Loránd University Budapest, HU
Ines Neundorf University of Cologne, DE
Andreas Pahl Heidelberg Pharma GmbH, Ladenburg, DE
Jan Anderl Heidelberg Pharma GmbH, Ladenburg, DE
Umberto Piarulli Universitá degli Studi dell’ Insubria, IT
Norbert Sewald Bielefeld University (Co-ordinator), DE
Christian Steinkühler Exiris, Rome, IT
József Tóvári National Institute of Oncology, Budapest, HU



The 5th International Bielefeld-CeBiTec Research Conference is jointly organised by the ETN MAGICBULLET, CeBiTec, Bielefeld University and the GFT e.V. (Gesellschaft zur Foerderung des Forschungs- und Technologietransfers in der Universitaet Bielefeld e.V.).

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642004.

eu flag yellow

2015 icrc magicbullet logo

cebitec logo


2013-icrc-zif  gft